Sticking With Long Plays

 | Jan 23, 2012 | 11:41 AM EST  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

OIH

,

aapl

,

dtlk

,

elx

,

end

,

aumn

,

jazz

Many market players were anticipating a sell-the-news reaction to Thursday night's action. It didn't happen on Friday, and they are still leaning the wrong way, waiting for this market to reverse. A big drop in bonds is fanning talk about a rotation into equities, which is contributing to the strength, but this looks primarily like good, old-fashioned squeeze action so far.

Breadth is very solid, with 3450 gainers to 1650 decliners.

The Market Vectors Oil Services ETF (OIH) is down, but all other major sectors are up, with banks, precious metals, coal and natural gas leading. Apple (AAPL) is also helping the bullish cause after a poor day Friday, as market players anticipate its report tomorrow night.

Although I'm itching to try an index short, I'm not seeing any real weakness yet, so I'm sticking with long plays. Silver has some momentum, and my stock of the week, Golden Minerals (AUMN), which I've discussed previously, is doing well. There are some good bounces in natural-gas-related plays, and I'm taking some Endeavour International (END) in the energy sector.

I'm particularly pleased to see some better action in small-cap technology stocks, and I'm playing a few things such as Datalink (DTLK) and Emulex (ELX). Jazz Pharmaceuticals (JAZZ) is developing nicely in the biotech group, and I'm looking to add back shares there.

We have some good trading but the market is in nose-bleed territory. I can certainly understand why many are anticipating a reverse soon, but I've learned far too often that it is better to wait for weakness rather than anticipate it.

Columnist Conversations

Lang:
The statement from the FOMC yesterday contained very little to surprise us and given the rebound and then give...
I think the action in the markets yesterday implies not that gdp was weaker than expected but that it might be...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market gets hit from impact of sanctions against Russia for second day in row but manages to rally a bit to en...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.